Overview
ChineseInvestors.com, Inc. and subsidiaries. ("the Company", "we" or "us")
endeavors to be an innovative company, specializing in (a) providing real-time
market commentary, analysis, and educational related endeavors in Chinese
language character sets (traditional and simplified), (b) providing support
services to our various partners wishing to have a Chinese language
communications component, (c) providing consultative services to smaller private
companies considering becoming a public company, (d) providing various
advertising as well as public relation support services, and (e) other services
we may identify having the potential to create value or partnership opportunity
with our existing services.
The Company incurred $2,746,581 in additional debt obligations from individual
lenders and $403,421 from institutional lenders for total new debt of $3,150,002
in the nine months ended February 29, 2020. The Company continues to develop its
subscription business and its investor relations business. These investor
relations clients represent companies whose shares are traded in various public
markets including the OTCBB, NASDAQ, and NYSE exchanges.
XiBiDi Biotechnology Co., Ltd.
In March 2017, the Company established and registered XiBiDi Biotechnology Co.
Ltd./CBD Biotechnology Co. Ltd. ("CBD Biotech") in Pudong Free-Trade Area in
Shanghai, Peoples Republic of China, founded as a wholly owned foreign
enterprise ("WOFE") of ChineseInvestors.com Inc. CBD Biotech's primary focus is
online and retail sales of industrial hemp-infused skincare products and liquor
in the PRC. CBD Biotech's first product launch was CBD Magic Hemp Series, an
industrial hemp-infused skincare line.
Thereafter in November 2017, CBD Biotech obtained Wholesale Alcohol License from
the Shanghai Wine Monopoly Bureau, effective October 24, 2017 for a three-year
term, which allows CBD Biotech to act as a liquor distributor. CBD Biotech
entered into a wholesale agreement with China GuiZhou HanTai Wine, Inc. to
distribute its liquor product - Yantai 1985. The Company announced plans to spin
off CBD Biotech in February 2018, which was later postponed. Thereafter, in
December 2018, the Company announced that it had retained an underwriter for the
planned Initial Public Offering ("IPO") of CBD Biotech concurrently with a
listing on a national securities exchange.
On or about February 27, 2019, CBD Biotech, Inc., an exempted company with
limited liability incorporated in the Cayman Islands, was formed ("CBD Biotech
Cayman"). CBD Biotech Cayman is solely owned by Wei Wang, ChineseInvestors.com,
Inc.'s Chief Executive Officer, and Alex Hamilton, Chairman and Chief Financial
Officer of CBD Biotech. The Company was prepared to enter into a Share Exchange
Agreement with CBD Biotech and the shareholders of CBD Biotech Cayman (the
"Share Exchange Agreement"). However, on or about November 11, 2019, Hemp Logic,
CBD Biotech and ChineseInvestors.com, Inc. entered into a Share Exchange
Agreement ("SEA") pursuant to which the Company sold/transferred to Hemp Logic
its one hundred percent (100%) equity interest in CBD Biotech in exchange for
newly issued Class A Common Stock, par value $0.0001 and Class B Common Stock,
par value $0.0001. CBD Biotech become a wholly-owned subsidiary of Hemp Logic
and the Company become a majority owner of Hemp Logic. Hemp Logic issued the
Company an aggregate of four million eight hundred fort- one thousand seven
hundred thirty-nine (4,841,739) newly-issued 2,521,739 shares of Class A Common
Stock and 2,320,000 shares of Class B Common Stock of Hemp Logic in the
aggregate (the "Hemp Logic Shares"), After the SEA, one hundred percent ("100%")
of the equity interests of CBD Biotech are owned by Hemp Logic and approximately
83.9% of Hemp Logic is owned by the Company. The closing of the exchange took
place on December 31, 2019. All operations will be conducted through Hemp Logic
and CBD Biotech will continue to operate two business lines, cosmetics and
liquor. As of February 29, 2020, the Company own 77% of Hemp Logic Inc.
As of February 29, 2020, CBD Biotech employed fifteen (15) full-time employees
in its Shanghai Office in a variety of administrative and operational
capacities. Its CFO, Alex Hamilton, is based in the Company's New York office.
32
ChineseHempOil.com, Inc.
In April 2017, the Company established ChineseHempOil.com, Inc. dba "Chinese
Wellness Center," a Delaware corporation ("CHO"), as a wholly owned subsidiary
of the Company. CHO is responsible for online and retail sales of industrial
hemp products in the United States. Chinese Wellness Center is the Company's
retail store located in the predominantly Chinese community of San Gabriel,
California, next to the Company's headquarters. In or about February 2018, the
Company announced its plans to spin off CHO, which was later postponed. In
December 2018, the Company announced that it had retained an underwriter for the
planned Initial Public Offering ("IPO") of CBD Biotech, concurrently with a
listing on a national securities exchange. CHO will no longer be part of this
planned spin-off.
As of February 29, 2020, ChineseHempOil.com, Inc. employed two (2) full-time
employees in the United States.
CBD Biotechnology Co. Ltd.
In June 2017, the Company formed CBD Biotechnology Ltd. ("CBD Canada"), a
corporation incorporated in the Province of British Columbia, which is
anticipated to focus on the sales of industrial hemp- products, via online and
other distribution channels. CBD Canada has not generated any income as of
February 29, 2020.
Newcoins168.com LTD
On or about January 25, 2018, a certificate of incorporation was filed with the
Registrar in St. Vincent and the Grenadines establishing Newcoins168.com, LTD
("Newcoins Grenadine"). Pursuant to the Certificate of Incumbency, issued on May
28, 2018, the Registered Office for Newcoins Grenadine is Suite 305, Griffith
Corporate Centre, Beachmont, P.O. Box 15 1 O, Kingstown. Saint Vincent and the
Grenadines. All of Newcoins Grenadine's registered shares, 1000 shares, were
issued to ChineseInvestors.com, Inc.'s CEO, Wei Wang. Wei Wang holds these
shares as agent for ChneseInvestors.com, Inc. Newcoins Grenadine's total
authorized capital is $1,000,000.
Newcoins Grenadine was established to develop a full-service retail Forex and
CFD platform that connects with one of the market's leading trading platforms to
provide customers with Forex/CFD market trading service, as well as offering
education, market information, and insights for customers related to the
Forex/CFD market. The platform had 992 subscribers in the Philippines, Malaysia,
Indonesia, Russia, Hong Kong, Brunei and India and no registered users in the
US. Newcoins Grenadine's registered users never funded their accounts.
On or about February 27, 2019 Newcoins Grenadine entered into a Technology
Solution Agreement with Match-Trade Technologies ("MTT"), pursuant to which MTT
agreed to provide Newcoins Grenadine with a trading infrastructure (integrated
electronic systems and software) designed to offer a platform to Newcoins
Grenadine's clients for the trading of financial products, i.e., Forex and/or
CFDs and/or other financial instruments offered to Newcoins Grenadine's clients.
In or about March 2019, Newcoins Grenadine entered into an agreement with
Forexstreet S.L. ("FS") pursuant to which FS agreed to provide daily news feeds
and updates. Newcoins Grenadine platform has not generated any revenues to date.
Given the platform's target audience is outside of the US and China, it has been
challenging to convert leads generated as a result of advertising and marketing
efforts into account deposits that will lead to trading due to the significant
language barrier. The Company has determined that the expense that would be
required to hire and trains native speakers to assist the platform's potential
account holders/traders would outweigh the potential gain and has decided to
focus its efforts on the Company's core, traditional business lines. In an
effort to reduce fixed costs associated with the platform, the Company cancelled
these service agreements and discontinued the platform in August 2019.
Newcoins168.com Digital Media Technology Ltd.
In April 2018, the Company established a wholly owned foreign enterprise,
NewCoins168.com Digital Media Technology Ltd (Shanghai), registered in China
Free Trade Zone with registered capital of 10 million RMB. As of February 29,
2020, NewCoins168 employed one (1) full-time employees in its Shanghai Office in
a variety of administrative and operational capacities.
33
CIIX Online LTD
In August 2018, the Company formed CIIX Online Ltd. ("CIIX Online"), a
corporation incorporated in the Province of British Columbia, which is
anticipated to focus on the sales of the Company's subscription service to
consumers.
As of February 29, 2020, CIIX Online employed one (1) part-time employee in a
variety of administrative and operational capacities.
Donald Capital, LLC
Donald Capital, LLC, is a Delaware limited liability company established on May
7, 2018. In exchange for capital contributions totaling $160,000 from
ChineseInvestors.com, Inc., the Company received a 24.9% interest in Donald
Capital LLC. The remaining 75.1% is held equally by Hamilton Strategy Group,
Inc. and McDonald Global Enterprises LLC. Alex Hamilton is the CFO of Hemp
Logic, Inc. and is the President of Donald Capital LLC. Mr. Hamilton is also the
owner of Hamilton Strategy Group. Donald Capital LLC is a registered broker
dealer approved by FINRA effective May 14, 2019. Donald Capital LLC will serve
clients around the globe in the private, micro, small and middle capitalization
arenas through pre-capital raise and strategic advisory, capital raise and other
services that will be offered through network partners. On or about February 5,
2020, by unanimous written consent of the Company's Board of Directors, the
Company approved a resolution to sell its 24.9% interest in Donald Capital LLC
to a qualified buyer on terms to be agreed upon. To date, no buyer has been
procured.
Business Environment and Trends
The global marketplace has gradually recovered. We understand that our business
is dependent upon the health of the financial markets as well as the financial
health of the participants in those markets. With the recovery of the financial
market, more market participants willing to subscribe our financial market
analysis programs and public companies eager to spend more on increasing media
exposure and developing investor relations.
For three and nine months ended February 29, 2020 compared to three and nine
months ended February 28, 2019.
Quarterly Revenues and Expenses
Subscription Revenues: For the three months ended February 29, 2020 and February
28, 2019, revenues were $253,475 and $229,220, respectively. For the nine months
ended February 29, 2020 and February 28, 2019, revenues were $621,390 and
$680,119, respectively. The decline in revenues was due to a decrease in the
Company's subscribers to such services.
Investor Relations-Service Revenues:For the three months ended February 29, 2020
and February 28, 2019, revenues were $103,332 and $147,664 respectively. For the
nine months ended February 29, 2020 and February 28, 2019, revenues were
$1,383,482 and $546,251 respectively. The increases were attributable to an
increase in investor relations clients.
Other Revenues: For the three months ended February 29, 2020 and February 28,
2019, revenues were $2 and $6,620 respectively. For the nine months ended
February 29, 2020 and February 28, 2019, revenues were $3,863 and $97,447
respectively. The decrease of $93,584 was due to the absence of consulting fees
generated from its subsidiary company Newcoins for the nine months ended
February 29, 2020.
Sales of CBD/Hemp Products: For the three months ended February 29, 2020 and
February 28, 2019, revenues were $86,956 and $1,061,318 respectively, for a
decrease of $974,362. For the nine months ended February 29, 2020 and February
28, 2019, revenues were $1,241,919 and $1,493,939 respectively. The $252,020
decrease was attributed to the decreased sales of the Company's industrial hemp
products and baijiu liquor products in China. It is believed that the outbreak
of Covid-19 in early January 2020 caused a slow of business and a reduction in
customers.
34
Cost of Revenue: Cost of services for the three months ended February 29, 2020
and 2019 were $297,739 and $253,135 respectively, for an increase of $44,604
over the same period in 2019. Cost of services for the nine months ended
February 29, 2020 and 2019 were $1,012,287 and $1,106,084 respectively, for a
decrease of $93,797 over the same period in 2019. Cost of products for the three
months ended February 29, 2020 and 2019 were $39,355 and $759,369 respectively,
for a decrease of $720,014. Cost of products for the nine months ended February
29, 2020 and 2019 were $917,627 and $958,198 respectively, for a decrease of
$40,571. This decrease was due to the Company's sale of its industrial hemp and
baijiu liquor products.
Gross profit (loss) and gross margin: The Company's gross margin on service
revenue decreased to 17% (gross profit $59,069 on $356,808 of revenue) in the
three months ended February 29, 2020 from 34% (gross profit $130,369 on $383,504
of revenue) in the three months ended February 28, 2019. The gross margin
decrease for service revenue is due to decreased investor relations clients and
revenues generated for these services. The Company's gross margin on service
revenue increased to 50% (gross profit $996,448 on $2,008,735 of revenue) in the
nine months ended February 29, 2020 from 16.4% (gross profit $217,733 on
$1,323,817 of revenue) in the nine months ended February 28, 2019. The Company's
gross margin on product sales increased to 55% ($47,601 on $86,956 of revenue)
in the three months ended February 29, 2020 from 28% ($301,949 on $1,061,318 of
revenue) in the three months ended February 28, 2019. The increase in gross
margin for product sales was due to reduced product retail pricing on industrial
hemp products and reduced sales expenses. The Company's gross margin on product
sales decreased to 26% ($324,292 on $1,241,919 of revenue) in the nine months
ended February 29, 2020 from 36% ($535,741 on $1,493,939 of revenue) in the nine
months ended February 28, 2019.
General & Administrative Expenses:For the three months ended February 29, 2020
and February 28, 2019, expenses were $1,757,366 and $3,273,479, respectively for
a decrease of $1,516,113 which was related to downsizing of staff and
independent contractors. For the nine months ended February 29, 2020 and
February 28, 2019, expenses were $6,535,822 and $7,850,987, respectively for a
decrease of $1,315,165 which was related to company implemented budgetary
control on certain expenditures such as office utilities, other general office
expenses, and company travel and entertainment in an effort to reduce the total
amount of General and Administrative Expenses.
Advertising Expenses: For the three months ended February 29, 2020 and February
28, 2019, expenses were $160,811 and $298,297 respectively. The decrease is due
to the Company's decreased advertising and news coverage across several
different platforms. For the nine months ended February 29, 2020 and 2019,
expenses were $720,544 and $977,431 respectively.
Bad Debt Expenses: For the three months ended February 29, 2020 and 2019,
expenses were $413,000 and $0 respectively. For the nine months ended February
29, 2020 and 2019, expenses were $593,238 and $0 respectively. These increases
are attributable to the bad debt allowance recorded by the Company for stock
receivable $173,475 from Ionix Technology Inc. and $413,000 from Luokung
Technology Corp for investor relations services performed.
Interest Income (expenses):For the three months ended February 29, 2020 and
2019, interest expense was $228,975 and $146,283, respectively for a difference
of $82,692 attributable to the one-year unsecured notes issued to various
individual lenders (refer to short-term notes for details). For the nine months
ended February 29, 2020 and 2019, interest expense was $599,352 and $195,194
respectively for an increase of $404,158.
Liquidity
The Company is currently addressing its liquidity concerns by building upon its
revenue generating subscription service products, increasing its
advertising-based revenues, increasing its offerings of other consulting
services, and sale of industrial hemp products. Since its inception in 1997, the
Company has, at times, relied primarily upon proceeds from private placements
and sales of shares of its equity securities to fund its operations. In the last
two years the Company raised $5,000,043 through the issuance of its Series
C-2016 convertible preferred stock and $10,371,050 through the issuance of its
Series D-2017 convertible preferred stock. We anticipate continuing to rely on
sales of our securities as well as increasing our general revenues in order to
continue to fund our business operations.
35
Plan of Continued Operations
Management's Plan for the fiscal year 2020
Business Development
Management recognizes that one of the Company's most significant assets is its
unique network of Chinese investors in the United States and worldwide; thus,
one of Management's immediate short-term goals is to focus on achieving
brand-marketing goals for both its core subscription and investor relations
business and its industrial hemp/CBD business. Management believes that this
demographic is likely to continue to grow, especially at the upper end of the
income scale, partly because Chinese are believed to be highly adaptive to the
economy, are believed to have the ability to see the bigger picture when it
comes to monetary investments in the stock market, and are believed to have the
ability to recognize and appreciate new trends in capital markets. Moreover,
Management also believes Chinese are an affluent demographic and they accumulate
disposable savings over and above other demographics. Having access to this
market that is open to the new ideas and opportunities gives the Company a
competitive edge over other companies that market to other demographics.
Management believes that its unique network not been maximized to capture its
full monetary value to the Company.
In light of current political events and the COVID-19 pandemic, Management
believes that the Chinese investor is even more focused and engaged when it
comes to staying up to date on investment markets, and is seeking new products,
subscription offerings and investor tools to serve such needs. The Company
recognizes this need and is responding through development of the same.
Beginning in February 2020, we adjusted our business model and enhanced our
YouTube programming to include free live broadcasts providing analysis and
updates on the U.S. Equity and Option Markets in a grass roots effort to
generate new leads, with no associated advertising fees. Subscriptions to our
free YouTube channel have grown from approximately 15,000 to 22,000 in six
weeks, with approximately 5%-10% of the free subscribers becoming paid
subscribers. This in turn increased our subscription revenues in recent months
as follows: approximately $260K in subscription revenues for the month ended
February 29, 2020 (the third largest month for subscription revenues in Company
history); approximately $510k in subscription revenues for the month ended March
31, 2020 (the highest single month for subscription revenues in Company
history); and approximately $80K in subscription revenues for the first week of
April 2020. Management will continue to add more content to its YouTube channel
over the next 6-12 months. We believe this business model, which has cost the
Company $0 in advertising fees, will afford us opportunities unlike we have seen
in the last twenty years (during which time the Company averaged $400k- $800k
per year in advertising costs for its subscription products). Management is
excited about the new market opportunities and if subscription revenues continue
as they have in February and March 2020, the Company hopes to become cash flow
positive with record revenues over next twelve (12) months.
Moreover, as part of its cost-cutting measures Management has closed two office
locations, one in San Gabriel, CA and one in New York City, NY, with plans to
close the office in Flushing, NY and one location in Shanghai. In addition
Management intends to cut overall advertising costs to less than $10k per month
over the next twelve (12) months.
In addition, management is exploring joint venture opportunities with partners
that are looking to reach our unique network of consumers. With regard to its
industrial hemp/CBD business in China, the Company has two New Hemp-Infused,
Skin-Friendly, Antimicrobial Sanitizer Products in development.
The Company will also continue to recruit and will seek to retain a talented and
knowledgeable workforce and more specifically, will work to strengthen its
existing sales force through enhanced training, allocation of resources and
providing cross-selling opportunities. As such, the Company does not contemplate
any further layoffs of its sales force other than in the normal course.
36
Budgetary Control
General and Administrative Expenses will be controlled and were reduced in both
the three and nine month periods ending February 29, 2020 as compared to the
same periods last year. As noted above, cash flows used in operations for the
nine months ended February 29, 2020 and February 28, 2019 were $5,237,878 and
$8,398,744, respectively. The decreased cash used in operations was due to a
reduction in general and administrative expenses used in operations. As of the
date of this filing, has relinquished one of its commercial leases in San
Gabriel, CA and its commercial lease in New York City, New York. In addition,
the Company has been forced to lay off employees in both the New York and
California offices whose primary duties related to cryptocurrency products,
marketing, and administrative support functions. The marketing and
administrative functions have been largely transferred to existing employees in
China.
The management has also implemented budgetary control on certain expenditures
such as office utilities, other general office expenses, and company travel and
entertainment in an effort to reduce the total amount of General and
Administrative Expenses to approximately $300,000 USD each month from the
current expenses of approximately $400,000, excluding current debt due and
owing.
Financing
The Company anticipates continuing to rely on sales of its securities to fund a
portion of its business operations in fiscal year 2020, plans to meet all of its
obligations, and will conform to all of the requirements to remaining a fully
reporting a public company, while increasing its market presence as well as
services offering spectrum.
© Edgar Online, source Glimpses